Further evidence of the involvement of alpha-2A-adrenergic receptor gene (ADRA2A) in inattentive dimensional scores of attention-deficit/hyperactivity disorder

被引：31
|
作者：
Roman, T [1 ]
Polanczyk, GV
Zeni, C
Genro, JP
Rohde, LA
Hutz, MH
机构：
[1] Fed Sch Med Sci Porto Alegre, Dept Morphol Sci, Porto Alegre, RS, Brazil
[2] Univ Fed Rio Grande do Sul, Dept Psychiat, Porto Alegre, RS, Brazil
[3] Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil
来源：
MOLECULAR PSYCHIATRY | 2006年 / 11卷 / 01期
关键词：
D O I：
10.1038/sj.mp.4001743
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：8 / 10
页数：4
相关论文
共 50 条
  • [41] Attention-deficit hyperactivity disorder and the adrenergic receptors α1C and α2C
    C L Barr
    K Wigg
    G Zai
    W Roberts
    M Malone
    R Schachar
    R Tannock
    J L Kennedy
    Molecular Psychiatry, 2001, 6 : 334 - 337
  • [42] Possible involvement of alpha-2A adrenergic receptors in attention deficit hyperactivity disorder: Radioligand binding and polymorphism studies
    Deupree, J. D.
    Smith, S. D.
    Kratochvil, C. J.
    Bohac, D.
    Ellis, C. R.
    Polaha, J.
    Bylund, D. B.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2006, 141B (08) : 877 - 884
  • [43] Attention-deficit hyperactivity disorder and the adrenergic receptors α1C and α2C
    Barr, CL
    Wigg, K
    Zai, G
    Roberts, W
    Malone, M
    Schachar, R
    Tannock, R
    Kennedy, JL
    MOLECULAR PSYCHIATRY, 2001, 6 (03) : 334 - 337
  • [44] Advances in Attention-Deficit Hyperactivity Disorder TreatmentA Focus on the Role of Noradrenergic and Alpha-2a Receptor Modulation
    CNS Drugs, 2009, 23 (Suppl 1) : 1 - 4
  • [45] Advances in Attention-Deficit Hyperactivity Disorder Treatment A Focus on the Role of Noradrenergic and Alpha-2a Receptor Modulation
    Spencer, Thomas J.
    Arnsten, Amy F. T.
    Scahill, Lawrence
    Wigal, Sharon B.
    CNS DRUGS, 2009, 23 : 1 - 4
  • [46] Further evidence from haplotype analysis for linkage of the dopamine D4 receptor gene and attention-deficit hyperactivity disorder.
    Barr, CL
    Wigg, KG
    Bloom, S
    Schachar, R
    Tannock, R
    Roberts, W
    Malone, M
    Kennedy, J
    MOLECULAR PSYCHIATRY, 1999, 4 : S80 - S80
  • [47] Association of the NMDA receptor subunit gene GRIN2B with attention-deficit/hyperactivity disorder (ADHD)
    Dorval, KM
    Wigg, KG
    Crosbie, J
    Tannock, R
    Kennedy, JL
    Ickowicz, A
    Pathare, T
    Malone, M
    Schachar, R
    Barr, CL
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2005, 138B (01) : 55 - 55
  • [48] GIRK2-A novel candidate gene for attention-deficit/hyperactivity disorder (ADHD)
    Roeser, C.
    Renner, T. J.
    Walitza, S.
    Dempfle, A.
    Nguyen, T.
    Romanos, M.
    Jacob, C.
    Schaefer, H.
    Warnke, A.
    Lesch, K. P.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S24 - S24
  • [49] SLC2A3: a new candidate gene for attention-deficit/hyperactivity disorder
    Merker, S.
    Ziegler, G.
    Weber, H.
    Mayer, U.
    Gross-Lesch, S.
    Reif, A.
    Lesch, K. P.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S58 - S59
  • [50] Mechanism of Action of α2A-Adrenergic Agonists in Attention-Deficit/Hyperactivity Disorder With or Without Oppositional Symptoms
    Stahl, Stephen M.
    JOURNAL OF CLINICAL PSYCHIATRY, 2010, 71 (03) : 223 - 224
12345